In-Vitro Assessment of Atrial Septal Defect Occluder Deployment: A Crucial Step in Occluding Atrial Septal Defects and Restoring Cardiac Function

This research article introduces an innovative Atrial Septal Defect (ASD) Occluder tailored for treating atrial septal defects. Crafted from nitinol wire, the occluder incorporates strategically placed PET fabric in its design, enhancing its thrombogenicity and occlusion efficacy. The primary objective of this occluder is to halt blood flow between the atria, thus correcting the defect's impact on cardiac function. Through rigorous in-vitro testing, the occluder's deployment via catheter and its performance and efficacy are comprehensively evaluated. The study focuses on assessing its ability to effectively obstruct blood flow across the defect site while minimizing the risk of adverse effects or complications. This research marks a significant advancement in interventional cardiology, offering a promising solution for managing atrial septal defects. By detailing the occluder's developmental trajectory and key design considerations, this study provides valuable insights for future research endeavors and clinical implementations in the field. Ultimately, this occluder holds the potential to improve patient outcomes and enhance the safety and efficacy of ASD closure procedures.